C. Levin, H. Perrin, and B. Combadiere, Tailored immunity by skin antigen-presenting cells, Human Vaccines & Immunotherapeutics, vol.161, issue.1, pp.27-3634299, 2015.
DOI : 10.1093/intimm/dxt031
URL : http://www.tandfonline.com/doi/pdf/10.4161/hv.34299?needAccess=true

M. Saclier, S. Cuvellier, M. Magnan, R. Mounier, and B. Chazaud, Monocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration, FEBS Journal, vol.18, issue.17, pp.4118-4130, 2013.
DOI : 10.1038/nm.2807
URL : http://onlinelibrary.wiley.com/doi/10.1111/febs.12166/pdf

B. Przybyla, Aging alters macrophage properties in human skeletal muscle both at rest and in response to acute resistance exercise, Experimental Gerontology, vol.41, issue.3, pp.320-327007, 2006.
DOI : 10.1016/j.exger.2005.12.007

B. Combadiere and C. Liard, Transcutaneous and intradermal vaccination, Human Vaccines, vol.7, issue.8, pp.811-827, 2011.
DOI : 10.4161/hv.7.8.16274
URL : http://www.tandfonline.com/doi/pdf/10.4161/hv.7.8.16274?needAccess=true

D. Duffy, Neutrophils Transport Antigen from the Dermis to the Bone Marrow, Initiating a Source of Memory CD8+ T Cells, Immunity, vol.37, issue.5, pp.917-929015, 2012.
DOI : 10.1016/j.immuni.2012.07.015

V. Abadie, Original Encounter with Antigen Determines Antigen-Presenting Cell Imprinting of the Quality of the Immune Response in Mice, PLoS ONE, vol.4, issue.12, 2009.
DOI : 10.1371/journal.pone.0008159.s006

J. J. Suschak, S. Wang, K. A. Fitzgerald, and S. Lu, A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines, The Journal of Immunology, vol.196, issue.1, pp.310-316, 2016.
DOI : 10.4049/jimmunol.1501836

H. Ishikawa, Z. Ma, and G. N. Barber, STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity, Nature, vol.80, issue.7265, pp.788-792, 2009.
DOI : 10.4049/jimmunol.171.11.5908
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664154/pdf

M. P. Rols, Mechanism by Which Electroporation Mediates DNA Migration and Entry into Cells and Targeted Tissues, Methods Mol Biol, vol.423, pp.19-33978, 2008.
DOI : 10.1007/978-1-59745-194-9_2

A. M. Keane-myers, M. Bell, D. Hannaman, and M. Albrecht, DNA Electroporation of Multi-agent Vaccines Conferring Protection Against Select Agent Challenge: TriGrid Delivery System, Methods Mol Biol, vol.1121, pp.325-336978, 2014.
DOI : 10.1007/978-1-4614-9632-8_29

S. Vasan, In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers, PLoS ONE, vol.12, issue.1, 2011.
DOI : 10.1371/journal.pone.0019252.s004

C. Nilsson, Intradermal HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees, AIDS Research and Human Retroviruses, vol.30, issue.S1, 2015.
DOI : 10.1089/aid.2014.5049.abstract

B. Puissant-lubrano, Control of vaccinia virus skin lesions by long-term-maintained IFN-??+TNF-??+ effector/memory CD4+ lymphocytes in humans, Journal of Clinical Investigation, vol.120, issue.5, pp.1636-1644, 2010.
DOI : 10.1172/JCI38506

A. Vogt, Hair follicle targeting, penetration enhancement and Langerhans cell activation make cyanoacrylate skin surface stripping a promising delivery technique for transcutaneous immunization with large molecules and particle-based vaccines, Experimental Dermatology, vol.1, issue.1, pp.73-75, 2015.
DOI : 10.1038/nm0795-705

S. Hansen and C. M. Lehr, Transfollicular delivery takes root: the future for vaccine design?, Expert Review of Vaccines, vol.66, issue.2, pp.5-7, 2014.
DOI : 10.1016/j.jconrel.2010.11.015
URL : http://www.tandfonline.com/doi/pdf/10.1586/14760584.2014.862500?needAccess=true

B. Combadiere, Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial, PLoS ONE, vol.192, issue.5, 2010.
DOI : 10.1371/journal.pone.0010818.s005
URL : https://hal.archives-ouvertes.fr/pasteur-00498527

A. Vogt, Transcutaneous Anti-Influenza Vaccination Promotes Both CD4 and CD8 T Cell Immune Responses in Humans, The Journal of Immunology, vol.180, issue.3, pp.1482-1489, 2008.
DOI : 10.4049/jimmunol.180.3.1482
URL : http://www.jimmunol.org/content/jimmunol/180/3/1482.full.pdf

H. Fan, Q. Lin, G. R. Morrissey, and P. A. Khavari, Immunization via hair follicles by topical application of naked DNA to normal skin, Nat Biotechnol, vol.17872, issue.870, p.12856, 1999.

R. T. Kenney, S. A. Frech, L. R. Muenz, C. P. Villar, and G. M. Glenn, Dose Sparing with Intradermal Injection of Influenza Vaccine, New England Journal of Medicine, vol.351, issue.22, pp.2295-2301, 2004.
DOI : 10.1056/NEJMoa043540

D. Hannaman, L. C. Dupuy, B. Ellefsen, and C. S. Schmaljohn, A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation, Vaccine, vol.34, issue.31, pp.3607-3612077, 2016.
DOI : 10.1016/j.vaccine.2016.04.077

J. E. Ledgerwood, Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans, Clinical and Vaccine Immunology, vol.19, issue.11, pp.1792-179705663, 2012.
DOI : 10.1128/CVI.05663-11
URL : http://cvi.asm.org/content/19/11/1792.full.pdf

A. Brave, S. Nystrom, A. K. Roos, and S. E. Applequist, Plasmid DNA vaccination using skin electroporation promotes poly-functional CD4 T-cell responses, Immunology and Cell Biology, vol.89, issue.3, pp.492-496, 2011.
DOI : 10.1038/mt.2009.120

C. Liard, Intradermal Immunization Triggers Epidermal Langerhans Cell Mobilization Required for CD8 T-Cell Immune Responses, Journal of Investigative Dermatology, vol.132, issue.3, pp.615-625346, 2011.
DOI : 10.1038/jid.2011.346
URL : https://doi.org/10.1038/jid.2011.346

J. F. Mann, Enhanced Immunogenicity of an HIV-1 DNA Vaccine Delivered with Electroporation via Combined Intramuscular and Intradermal Routes, Journal of Virology, vol.88, issue.12, pp.6959-696900183, 2014.
DOI : 10.1128/JVI.00183-14

V. Blazevic, Induction of Human Immunodeficiency Virus Type-1-Specific Immunity with a Novel Gene Transport Unit (GTU)-MultiHIV DNA Vaccine, AIDS Research and Human Retroviruses, vol.22, issue.7, pp.667-677667, 2006.
DOI : 10.1089/aid.2006.22.667

F. Martinon, Persistent Immune Responses Induced by a Human Immunodeficiency Virus DNA Vaccine Delivered in Association with Electroporation in the Skin of Nonhuman Primates, Human Gene Therapy, vol.20, issue.11, pp.1291-1307044, 2009.
DOI : 10.1089/hum.2009.044

E. Vardas, Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU??-Multi-HIVB, in untreated HIV-1 infected subjects, Vaccine, vol.30, issue.27, pp.4046-4054007, 2012.
DOI : 10.1016/j.vaccine.2012.04.007

A. Spentzou, Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of HIV???1 Vaccine Candidates, The Journal of Infectious Diseases, vol.201, issue.5, pp.720-729650492, 2010.
DOI : 10.1086/650492

O. Yang, Will we be able to ???spot??? an effective HIV-1 vaccine?, Trends in Immunology, vol.24, issue.2, pp.67-72, 2003.
DOI : 10.1016/S1471-4906(02)00034-0

M. S. Bennett, H. L. Ng, A. Ali, and O. Yang, Cross???Clade Detection of HIV???1???Specific Cytotoxic T Lymphocytes Does Not Reflect Cross???Clade Antiviral Activity, The Journal of Infectious Diseases, vol.197, issue.3, pp.390-397525281, 2008.
DOI : 10.1086/525281

D. Sawamura, Direct injection of plasmid DNA into the skin induces dermatitis by activation of monocytes through toll-like receptor 9, The Journal of Gene Medicine, vol.303, issue.5, pp.664-671709, 2005.
DOI : 10.4049/jimmunol.168.2.554

J. W. Hooper, A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation, Clinical Microbiology and Infection, vol.20, pp.110-117, 2014.
DOI : 10.1111/1469-0691.12553

C. Liard, Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses, Vaccine, vol.29, issue.37, pp.6379-6391, 2011.
DOI : 10.1016/j.vaccine.2011.04.080

N. Etchart, Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans, Vaccine, vol.25, issue.39-40, pp.6891-6899, 2007.
DOI : 10.1016/j.vaccine.2007.07.014

R. Pappu, S. Rutz, and W. Ouyang, Regulation of epithelial immunity by IL-17 family cytokines, Trends in Immunology, vol.33, issue.7, pp.343-349008, 2012.
DOI : 10.1016/j.it.2012.02.008

X. Song, X. He, X. Li, and Y. Qian, The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity, Cellular & Molecular Immunology, vol.189, issue.4, pp.418-431, 2016.
DOI : 10.4049/jimmunol.1103014

P. Kumar, K. Chen, and J. Kolls, Th17 cell based vaccines in mucosal immunity, Current Opinion in Immunology, vol.25, issue.3, pp.373-380011, 2013.
DOI : 10.1016/j.coi.2013.03.011
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721632/pdf

R. N. Coler, Vaccination Produces CD4 T Cells with a Novel CD154???CD40-Dependent Cytolytic Mechanism, The Journal of Immunology, vol.195, issue.7, pp.3190-31971501118, 2015.
DOI : 10.4049/jimmunol.1501118
URL : http://www.jimmunol.org/content/jimmunol/195/7/3190.full.pdf

S. Johnson, ABSTRACT, Journal of Virology, vol.89, issue.15, pp.7494-750500438, 2015.
DOI : 10.1128/JVI.00438-15
URL : https://hal.archives-ouvertes.fr/hal-01336771

J. Mpendo, A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults, PLOS ONE, vol.8, issue.11, 2015.
DOI : 10.1371/journal.pone.0134287.s011

Z. M. Ndhlovu, Elite Controllers with Low to Absent Effector CD8+ T Cell Responses Maintain Highly Functional, Broadly Directed Central Memory Responses, Journal of Virology, vol.86, issue.12, pp.6959-696900531, 2012.
DOI : 10.1128/JVI.00531-12
URL : http://jvi.asm.org/content/86/12/6959.full.pdf

Z. M. Ndhlovu, ABSTRACT, Journal of Virology, vol.89, issue.21, pp.10735-1074701527, 2015.
DOI : 10.1128/JVI.01527-15

J. Lisziewicz, DermaVir: A Novel Topical Vaccine for HIV/AIDS, Journal of Investigative Dermatology, vol.124, issue.1, pp.160-169, 2005.
DOI : 10.1111/j.0022-202X.2004.23535.x
URL : https://hal.archives-ouvertes.fr/hal-00129913

J. F. Mann, Mucosal Application of gp140 Encoding DNA Polyplexes to Different Tissues Results in Altered Immunological Outcomes in Mice, PLoS ONE, vol.105, issue.6, 2013.
DOI : 10.1371/journal.pone.0067412.s003

S. Guo, Electro-gene transfer to skin using a noninvasive multielectrode array, Journal of Controlled Release, vol.151, issue.3, pp.256-262, 2011.
DOI : 10.1016/j.jconrel.2011.01.014
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101286/pdf

S. Kos, Electrotransfer parameters as a tool for controlled and targeted gene expression in skin, Molecular Therapy - Nucleic Acids, vol.5, issue.356, p.65, 2016.
DOI : 10.1038/mtna.2016.65

I. Ilves, S. Kivi, and M. Ustav, Long-term episomal maintenance of bovine papillomavirus type 1 plasmids is determined by attachment to host chromosomes, which Is mediated by the viral E2 protein and its binding sites, J Virol, vol.73, pp.4404-4412, 1999.

D. K. Gill, Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories, PLoS ONE, vol.31, issue.1, 2010.
DOI : 10.1371/journal.pone.0014330.s001

H. Streeck, N. Frahm, and B. D. Walker, The role of IFN-?? Elispot assay in HIV vaccine research, Nature Protocols, vol.61, issue.4, pp.461-469, 2009.
DOI : 10.1186/1479-5876-3-20

D. J. Lewis, Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginally, PLoS One, vol.6, 2011.